GSK and Hansoh’s ADC clinches late-stage win, teeing up regulatory submission in China

GSK and Hansoh Pharmaceutical’s antibody-drug conjugate success validates their partnership, one of the many deals in which Big Pharma has tapped a China company for promising cancer candidates.